Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,288.05
      (
      -0.27%
      )
      US Tech 100
      14,356.40
      (
      0.25%
      )
      Dow Jones
      33,507.50
      (
      -0.47%
      )
      Brent Oil
      92.185
      (
      -0.96%
      )
      Bitcoin
      26,885.03
      (
      -0.52%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amarin Corp PLC (AMRN)

      7. Amarin Corp PLC (AMRN) News

      AMRN Amarin Corp PLC

      0.9201
      0.0102 (1.12%)
      After Hours
      Last Updated: 16:00:04
      Delayed by 15 minutes

      Register Free for Streaming Quotes & Tools

      Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

      Register
      Company Name Stock Ticker Symbol Market Type
      Amarin Corp PLC AMRN NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0102 1.12% 0.9201 16:00:04
      Open Price Low Price High Price Close Price Prev Close
      0.9243 0.90 0.9498 0.9201 0.9099
      more quote information »

      Recent News

      Date Time Source Heading
      9/29/202310:16IHNWFeaturedVolcon Announces First Shipment of Newly Updated Grunt EVO Electric Motorcycle Units
      9/12/202308:00GLOBEAmarin to Present at the 2023 Cantor Global Healthcare..
      9/05/202316:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      8/16/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/16/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      8/09/202316:05GLOBEAmarin Provides Pricing & Reimbursement Updates for VAZKEPA..
      8/08/202307:00GLOBEAmarin And Neopharm Announce Exclusive Commercialization..
      8/07/202307:00GLOBEScottish Medicines Consortium Accepts VAZKEPA® (icosapent..
      8/02/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/02/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/02/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/02/202308:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
      8/02/202308:34EDGAR2Form S-3 - Registration statement under Securities Act of..
      8/02/202307:11GLOBEAmarin Reports Second Quarter 2023 Financial Results
      8/02/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/02/202307:01EDGAR2Form 8-K - Current report
      7/31/202308:00GLOBEAmarin and Lotus Pharmaceuticals Announce Exclusive..
      7/28/202318:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
      7/26/202308:00GLOBELatest Research Evaluating Clinical Benefits of..
      7/25/202316:05GLOBEAmarin Receives Positive Recommendation from Spanish Drug..
      7/24/202321:24EDGAR2Form 8-K - Current report
      7/21/202321:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202321:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/20/202308:31EDGAR2Form 8-K - Current report
      7/20/202308:00GLOBEAmarin Board of Directors Announces Executive Compensation..
      7/18/202316:25EDGAR2Form 8-K - Current report
      7/18/202316:16GLOBEAmarin Appoints Patrick Holt as President and Chief..
      7/18/202316:15GLOBEAmarin Implements Organizational Restructuring to Strengthen..
      7/05/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      6/21/202309:00GLOBEAmarin Announces Vascepa® (Icosapent Ethyl) Approved to..
      6/01/202316:30GLOBEAmarin to Present at Two Upcoming Investor Conferences
      6/01/202306:00GLOBEAmarin Partner EddingPharm Receives Regulatory Approval for..
      5/12/202311:00GLOBEAmarin Highlights New Data Providing Potential Mechanistic..
      5/03/202307:00GLOBEAmarin Reports First Quarter 2023 Financial Results and..
      4/19/202308:00GLOBEAmarin to Report First Quarter 2023 Financial Results and..
      4/17/202307:00GLOBEAmarin Names Aaron Berg Interim President & Chief Executive..
      4/04/202308:00GLOBEAmarin Announces VAZKEPA® (Icosapent Ethyl) Approved by..
      3/16/202308:00GLOBEReconstituted Amarin Board Ready for the Challenge of..
      3/13/202307:35IHNWNightfood, Inc. (OTCQB: NGTF) now in Sonesta International..
      3/06/202316:05GLOBEAmarin Announces Board Departures
      3/06/202308:00GLOBEAmarin Highlights New Evidence of Therapeutic Value of EPA..
      3/05/202310:21GLOBEAmarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing..
      Your Recent History
      NASDAQ
      AMRN
      Amarin
      Register now to watch these stocks streaming on the ADVFN Monitor.

      Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

      Log in to InvestorsHub
      Register Now